Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis.

Doycheva D, Deuter C, Hetzel J, Frick JS, Aschoff P, Schuelen E, Zierhut M, Pfannenberg C.

Br J Ophthalmol. 2011 Sep;95(9):1290-4. doi: 10.1136/bjo.2010.182659. Epub 2010 Oct 8.

PMID:
20935307
2.

Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture.

Doycheva D, Pfannenberg C, Hetzel J, Deuter CM, Pavesio C, Kempf VA, Schuelen E, Aschoff P, Rao N, Zierhut M.

Ocul Immunol Inflamm. 2010 Jun;18(3):194-9. doi: 10.3109/09273948.2010.483318.

PMID:
20482398
4.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
5.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

6.

Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.

Liu BJ, Dong JC, Xu CQ, Zuo CT, Le JJ, Guan YH, Zhao J, Wu JF, Duan XH, Cao YX.

Chin Med J (Engl). 2009 Aug 5;122(15):1749-54.

PMID:
19781319
7.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
8.

Clinical utility of 18 Fluorodeoxyglucose (FDG)-PET/CT scans in patients with suspect ocular tuberculosis.

Mehta S.

Indian J Ophthalmol. 2013 Oct;61(10):603-5. doi: 10.4103/0301-4738.121091.

9.

Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis.

La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH, Misotten T, Bakker M, van Hagen MP, Rothova A.

Am J Ophthalmol. 2014 Apr;157(4):754-61. doi: 10.1016/j.ajo.2013.11.013. Epub 2013 Nov 18.

PMID:
24262781
10.

Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?

Chundru S, Wong CY, Wu D, Balon H, Palka J, Chang CY, Gaskill M, Cheng CY, Huang WS, Fink-Bennett D.

Nucl Med Commun. 2008 Jul;29(7):623-7. doi: 10.1097/MNM.0b013e3282fdc979.

PMID:
18528184
11.
12.

Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.

Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.

Haematologica. 2001 Mar;86(3):266-73.

13.

18F-FDG PET/CT for staging of penile cancer.

Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.

J Nucl Med. 2005 Sep;46(9):1460-5.

14.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
15.

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.

Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.

J Clin Oncol. 2009 Oct 1;27(28):4774-80. doi: 10.1200/JCO.2008.20.1822. Epub 2009 Aug 31.

PMID:
19720925
16.

QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis.

Mackensen F, Becker MD, Wiehler U, Max R, Dalpke A, Zimmermann S.

Am J Ophthalmol. 2008 Nov;146(5):761-6. doi: 10.1016/j.ajo.2008.06.012. Epub 2008 Aug 21.

PMID:
18718569
17.

The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.

Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.

J Nucl Med. 2009 Apr;50(4):506-12. doi: 10.2967/jnumed.108.056382. Epub 2009 Mar 16.

18.

18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.

Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE.

J Nucl Med. 2007 May;48(5):764-70.

19.

Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.

Cianchetti M, Mancuso AA, Amdur RJ, Werning JW, Kirwan J, Morris CG, Mendenhall WM.

Laryngoscope. 2009 Dec;119(12):2348-54. doi: 10.1002/lary.20638.

PMID:
19718744
20.

[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].

Zhao TT, Li JG, Li YM.

Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):206-9. Chinese.

PMID:
17649638

Supplemental Content

Support Center